Dermatology News and Research

Latest Dermatology News and Research

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows.

7 Feb 2023

Study finds link between tumor microbiome and immune system in sarcoma patients

In a significant new study, UC Davis Comprehensive Cancer Center researchers have uncovered a link between a patient's microbiome and their immune system that can potentially be used to improve the treatment of soft tissue sarcoma.

30 Jan 2023

Study identifies the DNA roots of resistance to targeted cancer therapy

A new clinical and preclinical study from UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy, providing a possible strategy to address a vexing issue in cancer therapeutics.

26 Jan 2023

Study finds fewer cases of melanoma among regular users of vitamin D supplements

Fewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds.

9 Jan 2023

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

According to recent estimates, over 140 million people from 50 countries regularly get exposed to arsenic through drinking water.

16 Dec 2022

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab - a novel, patient-tailored monoclonal antibody therapy - showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

HIV-positive people are protected by Covid vaccines

People infected with HIV who receive antiretroviral therapy form antibodies against Sars-Cov-2 after being vaccinated against Covid with mRNA vaccines.

9 Dec 2022

New Collaborative Research Center investigates how Treg cells influence immunological and tissue-specific diseases

The German Research Foundation (DFG) has approved the establishment and funding of the Collaborative Research Center/Transregio (CRC/TRR) 355 "Heterogeneity and functional specialization of regulatory T cells in distinct microenvironments".

2 Dec 2022

The business of clinical trials is booming. Private equity has taken notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

2 Dec 2022

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.

30 Nov 2022

Sick profit: Investigating private equity’s stealthy takeover of health care across cities and specialties

Two-year-old Zion Gastelum died just days after dentists performed root canals and put crowns on six baby teeth at a clinic affiliated with a private equity firm.

14 Nov 2022

Artificial intelligence-based method may help predict early-stage melanoma recurrence

Most deaths from melanoma - the most lethal form of skin cancer - occur in patients who were initially diagnosed with early-stage melanoma and then later experienced a recurrence that is typically not detected until it has spread or metastasized.

31 Oct 2022

$38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical.

26 Oct 2022

Extreme climatic events pose a significant threat to global dermatological health

The skin is a large, complex organ, and it serves as the body's primary interface with the environment, playing key roles in sensory, thermoregulatory, barrier, and immunological functioning.

20 Oct 2022

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Recently, authors highlighted the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in triggering the relapse of mycosis fungoides, a type of cutaneous T-cell lymphoma.

17 Oct 2022

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Organ damage occurs in up to 70 percent of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.

13 Oct 2022

Burt's Bees research shows the benefits of nature-based regimens to protect and restore skin health

Burt's Bees, the #1 dermatologist recommended natural skin care brand and a pioneer in this area, announced its latest research findings on the benefits of nature-based regimens to protect and restore skin health across various skin conditions, types, and tones.

30 Sep 2022

Dermatology News and Research

Latest Dermatology News and Research

Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer

Study finds link between tumor microbiome and immune system in sarcoma patients

Study identifies the DNA roots of resistance to targeted cancer therapy

Study finds fewer cases of melanoma among regular users of vitamin D supplements

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

HIV-positive people are protected by Covid vaccines

New Collaborative Research Center investigates how Treg cells influence immunological and tissue-specific diseases

The business of clinical trials is booming. Private equity has taken notice.

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

Sick profit: Investigating private equity’s stealthy takeover of health care across cities and specialties

Artificial intelligence-based method may help predict early-stage melanoma recurrence

$38,398 for a single shot of a very old cancer drug

Extreme climatic events pose a significant threat to global dermatological health

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Burt's Bees research shows the benefits of nature-based regimens to protect and restore skin health

Studies explore how differences in skin composition may lead to dermatological conditions

Duke University Hospital selected as Center of Excellence for treating cerebral cavernous malformations

Private equity sees the billions in eye care as firms target high-profit procedures

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Dermatology News and Research

Latest Dermatology News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in